IRIDEX Corporation - Asset Resilience Ratio
IRIDEX Corporation (IRIX) has an Asset Resilience Ratio of 0.00% as of September 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check IRIDEX Corporation PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1998–2017)
This chart shows how IRIDEX Corporation's Asset Resilience Ratio has changed over time. See IRIDEX Corporation balance sheet quality to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down IRIDEX Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see IRIDEX Corporation market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: IRIDEX Corporation maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
IRIDEX Corporation Industry Peers by Asset Resilience Ratio
Compare IRIDEX Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 6.89% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
Annual Asset Resilience Ratio for IRIDEX Corporation (1998–2017)
The table below shows the annual Asset Resilience Ratio data for IRIDEX Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2017-12-31 | 0.00% | $0.00 | $41.65 Million | -- |
| 2016-12-31 | 0.00% | $0.00 | $48.14 Million | -- |
| 2015-12-31 | 0.00% | $0.00 | $41.82 Million | -- |
| 2014-12-31 | 0.00% | $0.00 | $41.82 Million | -- |
| 2013-12-31 | 0.00% | $0.00 | $33.68 Million | -- |
| 2012-12-31 | 0.00% | $0.00 | $28.91 Million | -- |
| 2011-12-31 | 0.00% | $0.00 | $32.15 Million | -- |
| 2007-12-31 | 8.15% | $3.80 Million | $46.65 Million | -13.21pp |
| 2005-12-31 | 21.36% | $8.78 Million | $41.10 Million | +12.86pp |
| 2004-12-31 | 8.50% | $3.32 Million | $39.09 Million | -7.55pp |
| 2003-12-31 | 16.05% | $5.75 Million | $35.84 Million | +9.17pp |
| 2002-12-31 | 6.87% | $2.36 Million | $34.27 Million | -6.41pp |
| 2001-12-31 | 13.29% | $4.49 Million | $33.79 Million | +4.73pp |
| 2000-12-31 | 8.55% | $3.00 Million | $35.02 Million | -2.17pp |
| 1999-12-31 | 10.72% | $3.50 Million | $32.66 Million | -7.20pp |
| 1998-12-31 | 17.92% | $5.09 Million | $28.40 Million | -- |
About IRIDEX Corporation
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and Oc… Read more